Biotech

All Articles

Metsera coordinate with Amneal to secure down GLP-1 source

.With very early period 1 information now out in bush, metabolic illness ensemble Metsera is throwin...

Rivus posts data to support muscle-sparing obesity medication insurance claims

.Rivus Pharmaceuticals has revealed the information responsible for its period 2 excessive weight ga...

BMS spends $110M to develop T-cell treatment deal, assisting Excellent buy time to advance prioritized pipeline

.Bristol Myers Squibb is actually paying for Prime Medication $110 thousand upfront to establish rea...

Generate increases an additional $1B-plus Big Pharma collaboration

.Novartis has actually printer inked an offer possibly worth more than $1 billion with Flagship-foun...

Metsera GLP-1 data slice shows 7.5% weight reduction at 36 days

.Just recently debuted Metsera is actually unfolding some phase 1 data for its own GLP-1 receptor ag...

Flagship really hopes biotechs flock to Mirai to boost hereditary medications

.Among the hereditary medicines branches ethnicity, Flagship Pioneering is revealing a new provider ...

BioAge eyes $180M coming from IPO, personal placement for being overweight trials

.BioAge Labs is considering all around $180 million in preliminary proceeds from an IPO and also a p...

Merck's LAG-3 combination falls short colorectal cancer cells stage 3 study

.An attempt by Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colon cancer...

Spanish VC shuts $200M life scientific researches fund

.Spain-based Asabys Partners has actually finalized a fund of 180 thousand europeans ($ 200 thousand...

BioAge brings in $198M from IPO as excessive weight biotech participates in Nasdaq

.BioAge Labs is actually bringing in nearly $200 million via its own Nasdaq IPO this morning, along ...